294 related articles for article (PubMed ID: 7505017)
1. Antibody specificities of Thai and Australian scleroderma sera with topoisomerase I recombinant fusion proteins.
Cram DS; Fisicaro N; McNeilage LJ; Coppel RL; Harrison LC
J Immunol; 1993 Dec; 151(12):6872-81. PubMed ID: 7505017
[TBL] [Abstract][Full Text] [Related]
2. An immunodominant epitope on DNA topoisomerase I is conformational in nature: heterogeneity in its recognition by systemic sclerosis sera.
Kuwana M; Kaburaki J; Medsger TA; Wright TM
Arthritis Rheum; 1999 Jun; 42(6):1179-88. PubMed ID: 10366110
[TBL] [Abstract][Full Text] [Related]
3. Naturally occurring and disease-associated auto-antibodies against topoisomerase I: a fine epitope mapping study in systemic sclerosis and systemic lupus erythematosus.
Simon D; Czömpöly T; Berki T; Minier T; Peti A; Tóth E; Czirják L; Németh P
Int Immunol; 2009 Apr; 21(4):415-22. PubMed ID: 19211583
[TBL] [Abstract][Full Text] [Related]
4. B-Cell epitope mapping of DNA topoisomerase I defines epitopes strongly associated with pulmonary fibrosis in systemic sclerosis.
Rizou C; Ioannidis JP; Panou-Pomonis E; Sakarellos-Daitsiotis M; Sakarellos C; Moutsopoulos HM; Vlachoyiannopoulos PG
Am J Respir Cell Mol Biol; 2000 Mar; 22(3):344-51. PubMed ID: 10696071
[TBL] [Abstract][Full Text] [Related]
5. T cell lines from systemic sclerosis patients and healthy controls recognize multiple epitopes on DNA topoisomerase I.
Hu PQ; Oppenheim JJ; Medsger TA; Wright TM
J Autoimmun; 2006 Jun; 26(4):258-67. PubMed ID: 16735104
[TBL] [Abstract][Full Text] [Related]
6. The HLA-DR and DQ genes control the autoimmune response to DNA topoisomerase I in systemic sclerosis (scleroderma).
Kuwana M; Kaburaki J; Okano Y; Inoko H; Tsuji K
J Clin Invest; 1993 Sep; 92(3):1296-301. PubMed ID: 7690776
[TBL] [Abstract][Full Text] [Related]
7. Diversity and plasticity of the anti-DNA topoisomerase I autoantibody response in scleroderma.
Henry PA; Atamas SP; Yurovsky VV; Luzina I; Wigley FM; White B
Arthritis Rheum; 2000 Dec; 43(12):2733-42. PubMed ID: 11145031
[TBL] [Abstract][Full Text] [Related]
8. Highly restricted TCR-alpha beta usage by autoreactive human T cell clones specific for DNA topoisomerase I: recognition of an immunodominant epitope.
Kuwana M; Medsger TA; Wright TM
J Immunol; 1997 Jan; 158(1):485-91. PubMed ID: 8977226
[TBL] [Abstract][Full Text] [Related]
9. Epitope mapping of recombinant HeLa SmB and B' peptides obtained by the polymerase chain reaction.
Elkon KB; Hines JJ; Chu JL; Parnassa A
J Immunol; 1990 Jul; 145(2):636-43. PubMed ID: 1694885
[TBL] [Abstract][Full Text] [Related]
10. Direct binding of anti-DNA topoisomerase I autoantibodies to the cell surface of fibroblasts in patients with systemic sclerosis.
Hénault J; Tremblay M; Clément I; Raymond Y; Senécal JL
Arthritis Rheum; 2004 Oct; 50(10):3265-74. PubMed ID: 15476238
[TBL] [Abstract][Full Text] [Related]
11. Epitope mapping with a recombinant human 68-kDa (U1) ribonucleoprotein antigen reveals heterogeneous autoantibody profiles in human autoimmune sera.
Guldner HH; Netter HJ; Szostecki C; Lakomek HJ; Will H
J Immunol; 1988 Jul; 141(2):469-75. PubMed ID: 2454993
[TBL] [Abstract][Full Text] [Related]
12. At least three distinct B cell epitopes reside in the C-terminal half of La protein, as determined by a recombinant DNA approach.
Rauh AJ; Hornig H; Lührmann R
Eur J Immunol; 1988 Dec; 18(12):2049-57. PubMed ID: 2464497
[TBL] [Abstract][Full Text] [Related]
13. MHC class II associations with autoantibody and T cell immune responses to the scleroderma autoantigen topoisomerase I.
Rands AL; Whyte J; Cox B; Hall ND; McHugh NJ
J Autoimmun; 2000 Dec; 15(4):451-8. PubMed ID: 11090244
[TBL] [Abstract][Full Text] [Related]
14. Identification of a universal B cell epitope on DNA topoisomerase I, an autoantigen associated with scleroderma.
Kato T; Yamamoto K; Takeuchi H; Okubo M; Hara E; Nakada S; Oda K; Ito K; Nishioka K
Arthritis Rheum; 1993 Nov; 36(11):1580-7. PubMed ID: 7694585
[TBL] [Abstract][Full Text] [Related]
15. Anti-topoisomerase I autoantibodies in systemic sclerosis.
Czömpöly T; Simon D; Czirják L; Németh P
Autoimmun Rev; 2009 Jul; 8(8):692-6. PubMed ID: 19393194
[TBL] [Abstract][Full Text] [Related]
16. Longitudinal analysis of autoantibody response to topoisomerase I in systemic sclerosis.
Kuwana M; Kaburaki J; Mimori T; Kawakami Y; Tojo T
Arthritis Rheum; 2000 May; 43(5):1074-84. PubMed ID: 10817562
[TBL] [Abstract][Full Text] [Related]
17. Autoantibodies to BCOADC-E2 in patients with primary biliary cirrhosis recognize a conformational epitope.
Leung PS; Chuang DT; Wynn RM; Cha S; Danner DJ; Ansari A; Coppel RL; Gershwin ME
Hepatology; 1995 Aug; 22(2):505-13. PubMed ID: 7543435
[TBL] [Abstract][Full Text] [Related]
18. Autoantibodies against topoisomerase I detected with the natural enzyme and overlapping recombinant peptides.
Seelig HP; Schröter H; Ehrfeld H; Renz M
J Immunol Methods; 1993 Oct; 165(2):241-52. PubMed ID: 8228274
[TBL] [Abstract][Full Text] [Related]
19. A novel epitope on the C-terminus of SmD1 is recognized by the majority of sera from patients with systemic lupus erythematosus.
Riemekasten G; Marell J; Trebeljahr G; Klein R; Hausdorf G; Häupl T; Schneider-Mergener J; Burmester GR; Hiepe F
J Clin Invest; 1998 Aug; 102(4):754-63. PubMed ID: 9710444
[TBL] [Abstract][Full Text] [Related]
20. Epitope mapping and reactivity of autoantibodies to the E2 component of 2-oxoglutarate dehydrogenase complex in primary biliary cirrhosis using recombinant 2-oxoglutarate dehydrogenase complex.
Moteki S; Leung PS; Dickson ER; Van Thiel DH; Galperin C; Buch T; Alarcon-Segovia D; Kershenobich D; Kawano K; Coppel RL
Hepatology; 1996 Mar; 23(3):436-44. PubMed ID: 8617422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
